Reporting Segment Product Linearrow_drop_down Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Pre-Rev Biotech
Pre-Revenue Gene Editing Pharmaceuticals
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
1.19M 100.00%
keyboard_arrow_right keyboard_arrow_down
Pre-Rev Biotech
Pre-Revenue Gene Editing Pharmaceuticals
1.19M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.